Biodesix, Inc.BDSXNASDAQ

Loading chart...

Want to monitor BDSX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing.

Health Care and Social Assistance

Diagnostic Imaging Centers

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet

OWL Deadline: OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit

A Bottom-Basement Lithium Entry Point for Investor Opportunity: Elektros Inc., a Lithium Mining Company, Advances Strategic Communications

Microsoft's historic plunge: Why the company lost $357 billion in value despite strong results

Forget Tech Stocks: The Telehealth Stock That's Riding the AI Wave Better Than Big Tech

Disney Earnings Need to Show Parks and Streaming Growth

SJS Investment Boosts Ultra-Short Treasury Position by $6.39 Million

Could This Artificial Intelligence (AI) Stock Double in 2026?

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

Arons: "Extreme Growth" to Follow Rut, Top Picks in META, IBM & BA

NuScale Power Under $20: Your Last Chance to Buy?

Better Creative Tools Stock: Figma vs. Adobe

Gold, Silver Prices Dropped. Why Analysts Aren't Panicking.

Artificial Intelligence (AI) Could Deliver Another Decade of Growth. This Stock Is a Prime Candidate to Be a Winner.

Duke Energy urges Florida customers to reduce electric usage

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

2 Electric Vehicle Stocks That Could Make You Rich

MONDAY INVESTOR DEADLINE: Blue Owl Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

INVESTOR NOTICE: F5, Inc. (FFIV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Where Will D-Wave Quantum Stock Be in 5 Years?